ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

ClinicalTrials.gov ID: NCT02038881

Public ClinicalTrials.gov record NCT02038881. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 4:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine When Increasing the Number of Injections Compared to the Standard Regimen in Immunocompromised Subjects With HIV Infection

Study identification

NCT ID
NCT02038881
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bavarian Nordic
Industry
Enrollment
87 participants

Conditions and interventions

Conditions

Interventions

  • IMVAMUNE® Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 27, 2014
Primary completion
May 9, 2017
Completion
May 9, 2017
Last update posted
Apr 1, 2020

2014 – 2017

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Health for Life Clinic Little Rock Little Rock Arkansas 72207
Quest Clinical Research San Francisco California 94115
Dupont Circle Physicians Group Washington D.C. District of Columbia 20009
Infectious Disease Associats of NW Florida Center for Prevention and Treatment of Infections Infectious Diseases Associates of NW FL Pensacola Florida 32504
Rowan Tree Medical Wilton Manors Florida 33305
University of Illinois - Chicago Chicago Illinois 60612
University of Iowa Departments of Internal Medicine and Microbiology University of Iowa Iowa City Iowa 52242
Washington University School of Medicine St Louis Missouri 63110
University of Pennsylvania Clinical Trials Unit Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02038881, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2020 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02038881 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →